In vivo CRISPR screening directly targeting testicular cells

Cell Genom. 2024 Mar 13;4(3):100510. doi: 10.1016/j.xgen.2024.100510. Epub 2024 Mar 5.

Abstract

CRISPR-Cas9 short guide RNA (sgRNA) library screening is a powerful approach to understand the molecular mechanisms of biological phenomena. However, its in vivo application is currently limited. Here, we developed our previously established in vitro revival screening method into an in vivo one to identify factors involved in spermatogenesis integrity by utilizing sperm capacitation as an indicator. By introducing an sgRNA library into testicular cells, we successfully pinpointed the retinal degeneration 3 (Rd3) gene as a significant factor in spermatogenesis. Single-cell RNA sequencing (scRNA-seq) analysis highlighted the high expression of Rd3 in round spermatids, and proteomics analysis indicated that Rd3 interacts with mitochondria. To search for cell-type-specific signaling pathways based on scRNA-seq and proteomics analyses, we developed a computational tool, Hub-Explorer. Through this, we discovered that Rd3 modulates oxidative stress by regulating mitochondrial distribution upon ciliogenesis induction. Collectively, our screening system provides a valuable in vivo approach to decipher molecular mechanisms in biological processes.

Keywords: CRISPR screening; Hub-Explorer; in vivo genome-wide screening; multi-omics; spermatogenesis.

MeSH terms

  • Humans
  • Male
  • RNA, Guide, CRISPR-Cas Systems*
  • Semen*
  • Spermatids
  • Spermatogenesis / genetics
  • Testis

Substances

  • RNA, Guide, CRISPR-Cas Systems